InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength

Go back to InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
Gilead Sciences (NASDAQ: GILD) Delayed: 134.28 -2.02 (1.48%)
Previous Close $136.30    52 Week High $108.63 
Open $137.61    52 Week Low $71.39 
Day High $140.61    P/E 74.19 
Day Low $134.09    EPS $1.81 
Volume 6,902,332       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.76 -1.01 (1.91%)
Previous Close $52.77    52 Week High $45.58 
Open $51.07    52 Week Low $37.82 
Day High $52.27    P/E N/A 
Day Low $51.04    EPS $0.00 
Volume 10,759,761       

InterMune, Inc. (NASDAQ: ITMN) Delayed: 73.89 --0 (-0%)
Previous Close $73.89    52 Week High $74.24 
Open $1.07    52 Week Low $10.95 
Day High $73.89    P/E N/A 
Day Low $73.89    EPS $-2.67 
Volume      

NOVARTIS AG (NYSE: NVS) Delayed: 153.76 +1.03 (0.67%)
Previous Close $152.73    52 Week High $89.15 
Open $153.97    52 Week Low $69.84 
Day High $155.30    P/E N/A 
Day Low $153.14    EPS $0.00 
Volume 2,592,808